Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
21 studies found for:    NIAID | Open Studies | Influenza
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Open Studies | Influenza
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers
Condition: Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2
Intervention: Other: Live recombinantly derived A/Bethesda/MM1/H3N2 virus
2 Recruiting Influenza in People With Normal and Weakened Immune Systems
Condition: Influenza
Intervention:
3 Recruiting Screening Volunteers for Influenza Challenge Studies
Condition: Influenza, Human
Intervention:
4 Recruiting Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
Condition: Influenza
Intervention:
5 Recruiting Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A
Condition: Influenza A Virus Infection
Interventions: Biological: High-titer anti-influenza plasma;   Biological: Low-titer (control) anti-influenza plasma
6 Recruiting Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model
Condition: H1N1 Influenza Healthy Volunteers
Interventions: Biological: CR6261;   Biological: Placebo
7 Recruiting Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Condition: Influenza, Human
Interventions: Drug: Oseltamivir;   Drug: Oseltamivir Placebo
8 Recruiting Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG);   Biological: Placebo for IVIG
9 Not yet recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease
Condition: Influenza
Interventions: Biological: H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV);   Biological: H3N2v inactivated subvirion influenza vaccine;   Biological: Placebo
10 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
11 Recruiting Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine Inactivated
12 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013;   Drug: MF59 adjuvant
13 Not yet recruiting Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine
Conditions: Avian Influenza;   Influenza
Interventions: Biological: Influenza Multimeric-001 Vaccine;   Drug: MF59 adjuvant;   Biological: Monovalent influenza A/H7N9 virus vaccine;   Other: Placebo
14 Not yet recruiting Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus
Condition: Influenza, Human
Interventions: Biological: Seasonal LAIV;   Biological: Placebo;   Biological: Wild-type A/California/2009-like Influenza Virus
15 Recruiting Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 pLAIV;   Biological: H7N9 pIIV;   Biological: AS03 adjuvant
16 Recruiting Genetic and Environmental Factors in the Response to Influenza Vaccination
Conditions: Influenza;   Healthy
Interventions: Biological: FluMist® Quadrivalent;   Biological: Fluzone® Quadrivalent vaccine
17 Recruiting Acute Respiratory Infection Consortium
Condition: Influenza
Intervention:
18 Recruiting Respiratory Virus Outpatient Study (FLU 002 Plus)
Condition: Influenza and Other Novel Respiratory Viruses
Intervention:
19 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:
20 Recruiting Collection of Lung Fluid and Tissue Samples for Research
Conditions: Mycobacterium Infections, Atypical;   Granulomatous Disease, Chronic;   Job's Syndrome;   Influenza, Human
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.